NLR proteins: Integral members of innate immunity and mediators of inflammatory diseases

Journal of Leukocyte Biology

Volumn 83, Issue 1, 2008, Pages 13-30

  Wilmanski, Jeanette M ^a,b,c   Petnicki Ocwieja, Tanja ^a,b   Kobayashi, Koichi S ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c SAINT PETER'S UNIVERSITY   (United States)

Author keywords

Crohn's disease; Host pathogen interaction; NACHT; Nod2

Indexed keywords

CASPASE RECRUITMENT DOMAIN PROTEIN 15; CASPASE RECRUITMENT DOMAIN PROTEIN 4; FLAGELLIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA CONVERTING ENZYME; MITOGEN ACTIVATED PROTEIN KINASE; NEURONAL APOPTOSIS INHIBITORY PROTEIN; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN PROTEIN; PROTEIN IPAF; PROTEIN NALP1; UNCLASSIFIED DRUG;

BLAU SYNDROME; CARBOXY TERMINAL SEQUENCE; CROHN DISEASE; CYTOPLASM; ENZYME ACTIVITY; ENZYME REGULATION; FRANCISELLA; HUMAN; IMMUNE SYSTEM; INFLAMMATION; INNATE IMMUNITY; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SARCOIDOSIS; VITILIGO;

ANIMALS; HUMANS; IMMUNE SYSTEM DISEASES; IMMUNITY, NATURAL; INFLAMMATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 38149113537     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0607402     Document Type: Review

References (225)

1. Medzhitov, R., Janeway Jr., C. A. (1997) Innate immunity: the virtues of a nonclonal system of recognition. Cell 91, 295-298.
2. Takeda, K., Kaisho, T., Akira, S. (2003) Toll-like receptors. Annu. Rev. Immunol. 21, 335-376.
3. Inohara, N., Nunez, G. (2003) NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3, 371-382.
4. Kobayashi, K. S., Eynon, E. E., Flavell, R. A. (2003) Intracellular debugging. Nat. Immunol. 4, 652-654.
5. Belkhadir, Y., Subramaniam, R., Dangl, J. L. (2004) Plant disease resistance protein signaling: NBS-LRR proteins and their partners. Curr. Opin. Plant Biol. 7, 391-399.
6. Leister, D. (2004) Tandem and segmental gene duplication and recombination in the evolution of plant disease resistance gene. Trends Genet. 20, 116-122.
7. Staskawicz, B J. (2001) Genetics of plant-pathogen interactions specifying plant disease resistance. Plant Physiol. 125, 73-76.
8. Staskawicz, B. J., Ausubel, F. M., Baker, B. J., Ellis, J. G., Jones, J. D. (1995) Molecular genetics of plant disease resistance. Science 268, 661-667.
9. Mackey, D., Holt III, B. F., Wiig, A., Dangl, J. L. (2002) RIN4 interacts with Pseudomonas syringae type III effector molecules and is required for RPM1-mediated resistance in Arabidopsis. Cell 108, 743-754.
10. Kim, H. S., Desveaux, D., Singer, A. U., Patel, P., Sondek, J., Dangl, J. L. (2005) The Pseudomonas syringae effector AvrRpt2 cleaves its C-terminally acylated target, RIN4, from Arabidopsis membranes to block RPM1 activation. Proc. Natl. Acad. Sci. USA 102, 6496-6501.
11. Bertin, J., Nir, W. J., Fischer, C. M., Tayber, O. V., Errada, P. R., Grant, J. R., Keilty, J. J., Gosselin, M. L., Robison, K. E., Wong, G. H., Glucksmann, M. A., DiStefano, P. S. (1999) Human CARD4 protein is a novel CED-4/Apaf-1 cell death family member that activates NF-κB. J. Biol. Chem. 274, 12955-12958.
12. Inohara, N., Koseki, T., del Peso, L., Hu, Y., Yee, C., Chen, S., Carrio, R., Merino, J., Liu, D., Ni, J., Núñez, G. (1999) Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-κB. J. Biol. Chem. 274, 14560-14567.
13. Harton, J. A., Linhoff, M. W., Zhang, J., Ting, J. P. (2002) Cutting edge: CATERPILLER: a large family of mammalian genes containing CARD, pyrin, nucleotide-binding, and leucine-rich repeat domains. J. Immunol. 169, 4088-4093.
14. Tschopp, J., Martinon, F., Burns, K. (2003) NALPs: a novel protein family involved in inflammation. Nat. Rev. Mol. Cell Biol. 4, 95-104.
15. Inohara, N., Nunez, G. (2003) Cell death and immunity: NODs: intracellular proteins involved in inflammation and apoptosis. Nat. Rev. Immunol. 3, 371-382.
16. Koonin, E. V., Aravind, L. (2000) The NACHT family - a new group of predicted NTPases implicated in apoptosis and MHC transcription activation. Trends Biochem. Sci. 25, 223-224.
17. Bertin, J., DiStefano, P. S. (2000) The PYRIN domain: a novel motif found in apoptosis and inflammation proteins. Cell Death Differ. 7, 1273-1274.
18. Inohara, N., Nunez, G. (2001) The NOD: a signaling module that regulates apoptosis and host defense against pathogens. Oncogene 20, 6473-6481.
19. Martinon, F., Hofmann, K., Tschopp, J. (2001) The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr. Biol. 11, R118-R120.
20. Fairbrother, W. J., Gordon, N. C., Humke, E. W., O'Rourke, K. M., Starovasnik, M. A., Yin, J. P., Dixit, V. M. (2001) The PYRIN domain: a member of the death domain-fold superfamily. Protein Sci. 10, 1911-1918.
21. Pawlowski, K., Pio, F., Chu, Z., Reed, J. C., Godzik, A. (2001) PAAD - a new protein domain associated with apoptosis, cancer and autoimmune diseases. Trends Biochem. Sci. 26, 85-87.
22. Weber, C. H., Vincenz, C. (2001) The death domain superfamily: a tale of two interfaces? Trends Biochem. Sci. 26, 475-481.
23. Staub, E., Dahl, E., Rosenthal, A. (2001) The DAPIN family: a novel domain links apoptotic and interferon response proteins. Trends Biochem. Sci. 26, 83-85.
24. Birnbaum, M. J., Clem, R. J., Miller, L. K. (1994) An apoptosis-inhibiting gene from a nuclear polyhedrosis virus encoding a polypeptide with Cys/His sequence motifs. J. Virol. 68, 2521-2528.
25. Ammelburg, M., Frickey, T., Lupas, A. N. (2006) Classification of AAA+ proteins. J. Struct. Biol. 156, 2-11.
26. Tanabe, T., Chamaillard, M., Ogura, Y., Zhu, L., Qiu, S., Masumoto, J., Ghosh, P., Moran, A., Predergast, M. M., Tromp, G., Williams, C. J., Inohara, N., Núñez, G. (2004) Regulatory regions and critical residues of NOD2 involved in muramyl dipeptide recognition. EMBO J. 23, 1587-1597.
27. Duncan, J. A., Bergstralh, D. T., Wang, Y., Willingham, S. B., Ye, Z., Zimmermann, A. G., Ting, J. P. (2007) Cryopyrin/NALP3 binds ATP/dATP, is an ATPase, and requires ATP binding to mediate inflammatory signaling. Proc. Natl. Acad. Sci. USA 104, 8041-8046.
28. Girardin, S. E., Boneca, I. G., Viala, J., Chamaillard, M., Labigne, A., Thomas, G., Philpott, D. J., Sansonetti, P. J. (2003) Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869-8872.
29. Inohara, N., Ogura, Y., Fontalba, A., Gutierrez, O., Pons, F., Crespo, J., Fukase, K., Inamura, S., Kusumoto, S., Hashimoto, M., Foster, S. J., Moran, A. P., Fernandez-Luna, J. L., Nunez, G. (2003) Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278, 5509-5512.
30. Hasegawa, M., Yang, K., Hashimoto, M., Park, J. H., Kim, Y. G., Fujimoto, Y., Nunez, G., Fukase, K., Inohara, N. (2006) Differential release and distribution of Nod1 and Nod2 immunostimulatory molecules among bacterial species and environments. J. Biol. Chem. 281, 29054-29063.
31. Girardin, S. E., Boneca, I. G., Carneiro, L. A., Antignac, A., Jehanno, M., Viala, J., Tedin, K., Taha, M. K., Labigne, A., Zathringer, U., Coyle, A. J., DeStefano, P. S., Bertin, J., Sansonetti, P. J., Philpott, D. J. (2003) Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300, 1584-1587.
32. Opitz, B., Puschel, A., Beermann, W., Hocke, A. C., Forster, S., Schmeck, B., van Laak, V., Chakraborty, T., Suttorp, N., Hippenstiel, S. (2006) Listeria monocytogenes activated p38 MAPK and induced IL-8 secretion in a nucleotide-binding oligomerization domain 1-dependent manner in endothelial cells. J. Immunol. 176, 484-490.
33. Girardin, S. E., Tournebize, R., Mavris, M., Page, A. L., Li, X., Stark, G. R., Bertin, J., DiStefano, P. S., Yaniv, M., Sansonetti, P. J., Philpott, D. J. (2001) CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2, 736-742.
34. Kufer, T. A., Kremmer, E., Banks, D. J., Philpott, D. J. (2006) Role for Erbin in bacterial activation of Nod2. Infect. Immun. 74, 3115-3124.
35. Kobayashi, K. S., Chamaillard, M., Ogura, Y., Henegariu, O., Inohara, N., Nunez, G., Flavell, R. A. (2005) Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science 307, 731-734.
36. Hisamatsu, T., Suzuki, M., Reinecker, H. C., Nadeau, W. J., McCormick, B. A., Podolsky, D. K. (2003) CARD15/NOD2 functions as an antibacterial factor in human intestinal epithelial cells. Gastroenterology 124, 993-1000.
37. Vavricka, S. R., Musch, M. W., Chang, J. E., Nakagawa, Y., Phanvijhitsiri, K., Waypa, T. S., Merlin, D., Schneewind, O., Chang, E. B. (2004) hPepT1 transports muramyl dipeptide, activating NF-κB and stimulating IL-8 secretion in human colonic Caco2/bbe cells. Gastroenterology 127, 1401-1409.
38. Ismair, M. G., Vavricka, S. R., Kullak-Ublick, G. A., Fried, M., Mengin-Lecreulx, D., Girardin, S. E. (2006) hPepT1 selectively transports muramyl dipeptide but not Nod1-activating muramyl peptides. Can. J. Physiol. Pharmacol. 84, 1313-1319.
39. Charrier, L., Merlin, D. (2006) The oligopeptide transporter hPepT1: gateway to the innate immune response. Lab. Invest. 86, 538-546.
40. Merlin, D., Si-Tahar, M., Sitaraman, S. V., Eastburn, K., Williams, I., Liu, X., Hediger, M. A., Madara, J. L. (2001) Colonic epithelial hPepT1 expression occurs in inflammatory bowel disease: transport of bacterial peptides influences expression of MHC class 1 molecules. Gastroenterology 120, 1666-1679.
41. Charrier, L., Driss, A., Yan, Y., Nduati, V., Klapproth, J. M., Sitaraman, S. V., Merlin, D. (2006) hPepT1 mediates bacterial tripeptide fMLP uptake in human monocytes. Lab. Invest. 86, 490-503.
42. Herskovits, A. A., Auerbuch, V., Portnoy, D. A. (2007) Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog. 3, e51.
43. Gupta, D. K., Theisen, N., von Figura, K., Hasilik, A. (1985) Comparison of biosynthesis and subcellular distribution of lysozyme and lysosomal enzymes in U937 monocytes. Biochim. Biophys. Acta 847, 217-222.
44. Gallis, H. A., Miller, S. E., Wheat, R. W. (1976) Degradation of 14C-labeled streptococcal cell walls by egg white lysozyme and lysosomal enzymes. Infect. Immun. 13, 1459-1466.
45. Lenz, L. L., Mohammadi, S., Geissler, A., Portnoy, D. A. (2003) SecA2-dependent secretion of autolytic enzymes promotes Listeria monocytogenes pathogenesis. Proc. Natl. Acad. Sci. USA 100, 12432-12437.
46. Kapetanovic, R., Nahori, M. A., Balloy, V., Fitting, C., Philpott, D. J., Cavaillon, J. M., Adib-Conquy, M. (2007) Contribution of phagocytosis and intracellular sensing for cytokine production by Staphylococcus aureus-activated macrophages. Infect. Immun. 75, 830-837.
47. Franchi, L., Am, A., Body-Malapel, M., Kanneganti, T. D., Ozoren, N., Jagirdar, R., Inohara, N., Vandenabeele, P., Bertin, J., Coyle, A., Grant, E. P., Nunez, G. (2006) Cytosolic flagellin requires Ipaf for activation of caspase-1 and interleukin 1β in Salmonella-infected macrophages. Nat. Immunol. 7, 576-582.
48. Miao, E. A., Alpuche-Aranda, C. M., Dors, M., Clark, A. E., Bader, M. W., Miller, S. I., Aderem, A. (2006) Cytoplasmic flagellin activates caspase-1 and secretion of interleukin 1β via Ipaf. Nat. Immunol. 7, 569-575.
49. Molofsky, A. B., Byrne, B. G., Whitfield, N. N., Madigan, C. A., Fuse, E. T., Tateda, K., Swanson, M. S. (2006) Cytosolic recognition of flagellin by mouse macrophages restricts Legionella pneumophila infection. J. Exp. Med. 203, 1093-1104.
50. Ren, T., Zamboni, D. S., Roy, C. R., Dietrich, W. F., Vance, R. E. (2006) Flagellin-deficient Legionella mutants evade caspase-1- and Naip5-mediated macrophage immunity. PLoS Pathog. 2, e18.
51. Zamboni, D. S., Kobayashi, K. S., Kohlsdorf, T., Ogura, Y., Long, E. M., Vance, R. E., Kuida, K., Mariathasan, S., Dixit, V. M., Flavell, R. A., Dietrich, W. F., Roy, C. R. (2006) The Birc1e cytosolic pattern-recognition receptor contributes to the detection and control of Legionella pneumophila infection. Nat. Immunol. 7, 318-325.
52. Galan, J. E., Wolf-Watz, H. (2006) Protein delivery into eukaryotic cells by type III secretion machines. Nature 444, 567-573.
53. Backert, S., Meyer, T. F. (2006) Type IV secretion systems and their effectors in bacterial pathogenesis. Curr. Opin. Microbiol. 9, 207-217.
54. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A., Tschopp, J. (2006) Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440, 237-241.
55. Mariathasan, S., Weiss, D. S., Newton, K., McBride, J., O'Rourke, K., Roose-Girma, M., Lee, W. P., Weinrauch, Y., Monack, D. M., Dixit, V. M. (2006) Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440, 228-232.
56. Kanneganti, T. D., Ozoren, N., Body-Malapel, M., Am, A., Park, J. H., Franchi, L., Whitfield, J., Barchet, W., Colonna, M., Vandenabeele, P., Bertin, J., Coyle, A., Grant, E. P., Akira, S., Nunez, G. (2006) Bacterial RNA and small antiviral compounds activate caspase-1 through cryopyrin/Nalp3. Nature 440, 233-236.
57. Kanneganti, T. D., Lamkanfi, M., Kim, Y. G., Chen, G., Park, J. H., Franchi, L., Vandenabeele, P., Nunez, G. (2007) Pannexin-1-mediated recognition of bacterial molecules activates the cryopyrin inflammasome independent of Toll-like receptor signaling. Immunity 26, 433-443.
58. Sutterwala, F. S., Ogura, Y., Szczepanik, M., Lara-Tejero, M., Lichtenberger, G. S., Grant, E. P., Bertin, J., Coyle, A. J., Galan, J. E., Askenase, P. W., Flavell, R. A. (2006) Critical role for NALP3/CIAS1/cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity 24, 317-327.
59. Pelegrin, P., Surprenant, A. (2006) Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor. EMBO J. 25, 5071-5082.
60. Franchi, L., Kanneganti, T. D., Dubyak, G. R., Nunez, G. (2007) Differential requirement of P2X7 receptor and intracellular K+ for caspase-1 activation induced by intracellular and extracellular bacteria. J. Biol. Chem. 282, 18810-18818.
61. Boyden, E. D., Dietrich, W. F. (2006) Nalp1b controls mouse macrophage susceptibility to anthrax lethal toxin. Nat. Genet. 38, 240-244.
62. Faustin, B., Lartigue, L., Bruey, J. M., Luciano, F., Sergienko, E., Bailly-Maitre, B., Volkmann, N., Hanein, D., Rouiller, I., Reed, J. C. (2007) Reconstituted NALP1 inflammasome reveals two-step mechanism of caspase-1 activation. Mol. Cell 25, 713-724.
63. Kummer, J. A., Broekhuizen, R., Everett, H., Agostini, L., Kuijk, L., Martinon, F., van Bruggen, R., Tschopp, J. (2007) Inflammasome components NALP 1 and 3 show distinct but separate expression profiles in human tissues suggesting a site-specific role in the inflammatory response. J. Histochem. Cytochem. 55, 443-452.
64. Weiss, D. S., Henry, T., Monack, D. M. (2007) Francisella tularensis: activation of the inflammasome. Ann. N. Y. Acad. Sci. 1105, 219-237.
65. McCarthy, J. V., Ni, J., Dixit, V. M. (1998) RIP2 is a novel NF-κB-activating and cell death-inducing kinase. J. Biol. Chem. 273, 16968-16975.
66. Inohara, N., del Peso, L., Koseki, T., Chen, S., Nunez, G. (1998) RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem. 273, 12296-12300.
67. Thome, M., Hofmann, K., Burns, K., Martinon, F., Bodmer, J. L., Mattmann, C., Tschopp, J. (1998) Identification of CARDIAK, a RIP-like kinase that associates with caspase-1. Curr. Biol. 8, 885-888.
68. Inohara, N., Koseki, T., Lin, J., del Peso, L., Lucas, P. C., Chen, F. F., Ogura, Y., Nunez, G. (2000) An induced proximity model for NF-κ B activation in the Nod1/RICK and RIP signaling pathways. J. Biol. Chem. 275, 27823-27831.
69. Acehan, D., Jiang, X., Morgan, D. G., Heuser, J. E., Wang, X., Akey, C. W. (2002) Three-dimensional structure of the apoptosome: implications for assembly, procaspase-9 binding, and activation. Mol. Cell 9, 423-432.
70. Schafer, Z. T., Kornbluth, S. (2006) The apoptosome: physiological, developmental, and pathological modes of regulation. Dev. Cell 10, 549-561.
71. Zou, H., Henzel, W. J., Liu, X., Lutschg, A., Wang, X. (1997) Apaf-1, a human protein homologous to C. elegans CED-4, participates in cytochrome c-dependent activation of caspase-3. Cell 90, 405-413.
72. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., Wang, X. (1997) Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 91, 479-489.
73. Renatus, M., Stennicke, H. R., Scott, F. L., Liddington, R. C., Salvesen, G. S. (2001) Dimer formation drives the activation of the cell death protease caspase 9. Proc. Natl. Acad. Sci. USA 98, 14250-14255.
74. Boatright, K. M., Renatus, M., Scott, F. L., Sperandio, S., Shin, H., Pedersen, I. M., Ricci, J. E., Edris, W. A., Sutherlin, D. P., Green, D. R., Salvesen, G. S. (2003) A unified model for apical caspase activation. Mol. Cell 11, 529-541.
75. Ogura, Y., Inohara, N., Benito, A., Chen, F. F., Yamaoka, S., Nunez, G. (2001) Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-κB. J. Biol. Chem. 276, 4812-4818.
76. Albrecht, M., Domingues, F. S., Schreiber, S., Lengauer, T. (2003) Identification of mammalian orthologs associates PYPAF5 with distinct functional roles. FEBS Lett. 538, 173-177.
77. Martinon, F., Burns, K., Tschopp, J. (2002) The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-β. Mol. Cell 10, 417-426.
78. Cerretti, D. P., Kozlosky, C. J., Mosley, B., Nelson, N., Van Ness, K., Greenstreet, T. A., March, C. J., Kronheim, S. R., Druck, T., Cannizzaro, L. A., et al. (1992) Molecular cloning of the interleukin-1 β converting enzyme. Science 256, 97-100.
79. Chamaillard, M., Hashimoto, M., Horie, Y., Masumoto, J., Qiu, S., Saab, L., Ogura, Y., Kawasaki, A., Fukase, K., Kusumoto, S., Valvano, M. A., Foster, S. J., Mak, T. W., Nunez, G., Inohara, N. (2003) An essential role for NOD1 in host recognition of bacterial peptidoglycan containing diaminopimelic acid. Nat. Immunol. 4, 702-707.
80. Kobayashi, K., Inohara, N., Hernandez, L. D., Galan, J. E., Nunez, G., Janeway, C. A., Medzhitov, R., Flavell, R. A. (2002) RICK/Rip2/CARDIAK mediates signaling for receptors of the innate and adaptive immune systems. Nature 416, 194-199.
81. Li, J., Moran, T., Swanson, E., Julian, C., Harris, J., Bonen, D. K., Hedl, M., Nicolae, D. L., Abraham, C., Cho, J. H. (2004) Regulation of IL-8 and IL-1β expression in Crohn's disease associated NOD2/CARD15 mutations. Hum. Mol. Genet. 13, 1715-1725.
82. Yamamoto-Furusho, J. K., Barnich, N., Xavier, R., Hisamatsu, T., Podolsky, D. K. (2006) Centaurin β1 down-regulates nucleotide-binding oligomerization domains 1- and 2-dependent NF-κB activation. J. Biol. Chem. 281, 36060-36070.
83. McDonald, C., Chen, F. F., Ollendorff, V., Ogura, Y., Marchetto, S., Lecine, P., Borg, J. P., Nunez, G. (2005) A role for Erbin in the regulation of Nod2-dependent NF-κB signaling. J. Biol. Chem. 280, 40301-40309.
84. Barnich, N., Hisamatsu, T., Aguirre, J. E., Xavier, R., Reinecker, H. C., Podolsky, D. K. (2005) GRIM-19 interacts with nucleotide oligomerization domain 2 and serves as downstream effector of anti-bacterial function in intestinal epithelial cells. J. Biol. Chem. 280, 19021-19026.
85. Chen, C. M., Gong, Y., Zhang, M., Chen, J. J. (2004) Reciprocal cross-talk between Nod2 and TAK1 signaling pathways. J. Biol. Chem. 279, 25876-25882.
86. Humke, E. W., Shriver, S. K., Starovasnik, M. A., Fairbrother, W. J., Dixit, V. M. (2000) ICEBERG: a novel inhibitor of interleukin-1β generation. Cell 103, 99-111.
87. Mariathasan, S., Newton, K., Monack, D. M., Vucic, D., French, D. M., Lee, W. P., Roose-Girma, M., Erickson, S., Dixit, V. M. (2004) Differential activation of the inflammasome by caspase-1 adaptors ASC and Ipaf. Nature 430, 213-218.
88. Masumoto, J., Taniguchi, S., Ayukawa, K., Sarvotham, H., Kishino, T., Niikawa, N., Hidaka, E., Katsuyama, T., Higuchi, T., Sagara, J. (1999) ASC, a novel 22-kDa protein, aggregates during apoptosis of human promyelocytic leukemia HL-60 cells. J. Biol. Chem. 274, 33835-33838.
89. Conway, K. E., McConnell, B. B., Bowring, C. E., Donald, C. D., Warren, S. T., Vertino, P. M. (2000) TMS1, a novel proapoptotic caspase recruitment domain protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Res. 60, 6236-6242.
90. Srinivasula, S. M., Poyet, J. L., Razmara, M., Datta, P., Zhang, Z., Alnemri, E. S. (2002) The PYRIN-CARD protein ASC is an activating adaptor for caspase-1. J. Biol. Chem. 277, 21119-21122.
91. Geddes, B. J., Wang, L., Huang, W. J., Lavellee, M., Manji, G. A., Brown, M., Jurman, M., Cao, J., Morgenstern, J., Merriam, S., Glucksmann, M. A., DiStefano, P. S., Bertin, J. (2001) Human CARD12 is a novel CED4/Apaf-1 family member that induces apoptosis. Biochem. Biophys. Res. Commun. 284, 77-82.
92. Growney, J. D., Dietrich, W. F. (2000) High-resolution genetic and physical map of the Lgn1 interval in C57BL/6J implicates Naip2 or Naip5 in Legionella pneumophila pathogenesis. Genome Res. 10, 1158-1171.
93. Wright, E. K., Goodart, S. A., Growney, J. D., Hadinoto, V., Endrizzi, M. G., Long, E. M., Sadigh, K., Abney, A. L., Bernstein-Hanley, I., Dietrich, W. F. (2003) Naip5 affects host susceptibility to the intracellular pathogen Legionella pneumophila. Curr. Biol. 13, 27-36.
94. Lamkanfi, M., Am, A., Kanneganti, T. D., Munoz-Planillo, R., Chen, G., Vandenabeele, P., Fortier, A., Gros, P., Nunez, G. (2007) The Nod-like receptor family member Naip5/Birc1e restricts Legionella pneumophila growth independently of caspase-1 activation. J. Immunol. 178, 8022-8027.
95. Agostini, L., Martinon, F., Burns, K., McDermott, M. F., Hawkins, P. N., Tschopp, J. (2004) NALP3 forms an IL-1β-processing inflammasome with increased activity in Muckle-Wells autoinflammatory disorder. Immunity 20, 319-325.
96. Martinon, F., Agostini, L., Meylan, E., Tschopp, J. (2004) Identification of bacterial muramyl dipeptide as activator of the NALP3/cryopyrin inflammasome. Curr. Biol. 14, 1929-1934.
97. Gu, Y., Kuida, K., Tsutsui, H., Ku, G., Hsiao, K., Fleming, M. A., Hayashi, N., Higashino, K., Okamura, H., Nakanishi, K., Kurimoto, M., Tanimoto, T., Flavell, R. A., Sato, V., Harding, M. W., Livingston, D. J., Su, M. S. (1997) Activation of interferon-γ inducing factor mediated by interleukin-1β converting enzyme. Science 275, 206-209.
98. Schmitz, J., Owyang, A., Oldham, E., Song, Y., Murphy, E., McClanahan, T. K., Zurawski, G., Moshrefi, M., Qin, J., Li, X., Gorman, D. M., Bazan, J. F., Kastelein, R. A. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23, 479-490.
99. Wang, Y., Hasegawa, M., Imamura, R., Kinoshita, T., Kondo, C., Konaka, K., Suda, T. (2004) PYNOD, a novel Apaf-1/CED4-like protein is an inhibitor of ASC and caspase-1. Int. Immunol. 16, 777-786.
100. Richards, N., Schaner, P., Diaz, A., Stuckey, J., Shelden, E., Wadhwa, A., Gumucio, D. L. (2001) Interaction between pyrin and the apoptotic speck protein (ASC) modulates ASC-induced apoptosis. J. Biol. Chem. 276, 39320-39329.
101. Dowds, T. A., Masumoto, J., Chen, F. F., Ogura, Y., Inohara, N., Nunez, G. (2003) Regulation of cryopyrin/Pypaf1 signaling by pyrin, the familial Mediterranean fever gene product. Biochem. Biophys. Res. Commun. 302, 575-580.
102. Papin, S., Cuenin, S., Agostini, L., Martinon, F., Werner, S., Beer, H. D., Grutter, C., Grutter, M., Tschopp, J. (2007) The SPRY domain of pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1β processing. Cell Death Differ. 14, 1457-1466.
103. Chae, J. J., Wood, G., Masters, S. L., Richard, K., Park, G., Smith, B. J., Kastner, D. L. (2006) The B30.2 domain of pyrin, the familial Mediterranean fever protein, interacts directly with caspase-1 to modulate IL-1β production. Proc. Natl. Acad. Sci. USA 103, 9982-9987.
104. (1997) A candidate gene for familial Mediterranean fever. The French FMF Consortium. Nat. Genet. 17, 25-31.
105. (1997) Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell 90, 797-807.
106. Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A., Kolodner, R. D. (2001) Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat. Genet. 29, 301-305.
107. Brant, S. R., Shugart, Y. Y. (2004) Inflammatory bowel disease gene hunting by linkage analysis: rationale, methodology, and present status of the field. Inflamm. Bowel Dis. 10, 300-311.
108. Duerr, R. H., Barmada, M. M., Zhang, L., Achkar, J-P., Cho, J. H., Hanauer, S. B., Brant, S. R., Bayless, T. M., Baldassano, R. N., Weeks, D. E. (2002) Evidence for an inflammatory bowel disease locus on chromosome 3p26: linkage, transmission/disequilibrium and partitioning of linkage. Hum. Mol. Genet. 11, 2599-2606.
109. Ogura, Y., Lala, S., Xin, W., Smith, E., Dowds, T. A., Chen, F. F., Zimmermann, E., Tretiakova, M., Cho, J. H., Hart, J., Greenson, J. K., Keshav, S., Nunez, G. (2003) Expression of NOD2 in Paneth cells: a possible link to Crohn's ileitis. Gut 52, 1591-1597.
110. Hugot, J. P., Chamaillard, M., Zouali, H., Lesage, S., Cezard, J. P., Belaiche, J., Almer, S., Tysk, C., O'Morain, C. A., Gassull, M., Binder, V., Finkel, Y., Cortot, A., Modigliani, R., Laurent-Puig, P., Gower-Rousseau, C., Macry, J., Colombel, J. F., Sahbatou, M., Thomas, G. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603.
111. Ahmad, T., Armuzzi, A., Bunce, M., Mulcahy-Hawes, K., Marshall, S. E., Orchard, T. R., Crawshaw, J., Large, O., de Silva, A., Cook, J. T., Barnardo, M., Cullen, S., Welsh, K. I., Jewell, D. P. (2002) The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology 122, 854-866.
112. Bonen, D. K., Ogura, Y., Nicolae, D. L., Inohara, N., Saab, L., Tanabe, T., Chen, F. F., Foster, S. J., Duerr, R. H., Brant, S. R., Cho, J. H., Nunez, G. (2003) Crohn's disease-associated NOD2 variants share a signaling defect in response to lipopolysaccharide and peptidoglycan. Gastroenterology 124, 140-146.
113. Cuthbert, A. P., Fisher, S. A., Mirza, M. M., King, K., Hampe, J., Croucher, P. J., Mascheretti, S., Sanderson, J., Forbes, A., Mansfield, J., Schreiber, S., Lewis, C. M., Mathew, C. G. (2002) The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease. Gastroenterology 122, 867-874.
114. Lesage, S., Zouali, H., Cezard, J. P., Colombel, J. F., Belaiche, J., Almer, S., Tysk, C., O'Morain, C., Gassull, M., Binder, V., Finkel, Y., Modigliani, R., Gower-Rousseaus, C., Macry, J., Merlin, F., Chamaillard, M., Jannot, A. S〉, Thomas, G., Hugot, J. P. (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am. J. Hum. Genet. 70, 845-857.
115. Hampe, J., Grebe, J., Nikolaus, S., Solberg, C., Croucher, P. J., Mascheretti, S., Jahnsen, J., Moum, B., Klump, B., Krawczak, M., Mirza, M. M., Foelsch, U. R., Vatn, M., Schreiber, S. (2002) Association of NOD2 (CARD 15) genotype with clinical course of Crohn's disease: a cohort study. Lancet 359, 1661-1665.
116. Schmid, M., Fellermann, K., Wehkamp, J., Herrlinger, K., Stange, E. F. (2004) The role of defensins in the pathogenesis of chronic-inflammatory bowel disease. Z. Gastroenterol. 42, 333-338.
117. Wehkamp, J., Harder, J., Weichenthal, M., Schwab, M., Schaffeler, E., Schlee, M., Herrlinger, K. R., Stallmach, A., Noack, F., Fritz, P., Schroder, J. M., Bevins, C. L., Fellermann, K., Stange, E. F. (2004) NOD2 (CARD15) mutations in Crohn's disease are associated with diminished mucosal α-defensin expression. Gut 53, 1658-1664.
118. Wehkamp, J., Fellermann, K., Herrlinger, K. R., Bevins, C. L., Stange, E. F. (2005) Mechanisms of disease: defensins in gastrointestinal diseases. Nat. Clin. Pract. Gastroenterol. Hepatol. 2, 406-415.
119. Bouma, G., Strober, W. (2003) The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521-533.
120. Watanabe, T., Kitani, A., Murray, P. J., Strober, W. (2004) NOD2 is a negative regulator of Toll-like receptor 2-mediated T helper type 1 responses. Nat. Immunol. 5, 800-808.
121. Watanabe, T., Kitani, A., Murray, P. J., Wakatsuki, Y., Fuss, I. J., Strober, W. (2006) Nucleotide binding oligomerization domain 2 deficiency leads to dysregulated TLR2 signaling and induction of antigen-specific colitis. Immunity 25, 473-485.
122. Uehara, A., Sugawara, Y., Kurata, S., Fujimoto, Y., Fukase, K., Kusumoto, S., Satta, Y., Sasano, T., Sugawara, S., Takada, H. (2005) Chemically synthesized pathogen-associated molecular patterns increase the expression of peptidoglycan recognition proteins via Toll-like receptors, NOD1 and NOD2 in human oral epithelial cells. Cell. Microbiol. 7, 675-686.
123. Netea, M. G., Ferwerda, G., de Jong, D. J., Werts, C., Boneca, I. G., Jehanno, M., Van Der Meer, J. W., Mengin-Lecreulx, D., Sansonetti, P. J., Philpott, D. J., Dharancy, S., Girardin, S. E. (2005) The frameshift mutation in Nod2 results in unresponsiveness not only to Nod2- but also Nod1-activating peptidoglycan agonists. J. Biol. Chem. 280, 35859-35867.
124. Maeda, S., Hsu, L. C., Liu, H., Bankston, L. A., Iimura, M., Kagnoff, M. F., Eckmann, L., Karin, M. (2005) Nod2 mutation in Crohn's disease potentiates NF-κB activity and IL-1β processing. Science 307, 734-738.
125. Netea, M. G., Ferwerda, G., de Jong, D. J., Girardin, S. E., Kullberg, B. J., van der Meer, J. W. (2005) NOD2 3020insC mutation and the pathogenesis of Crohn's disease: impaired IL-1β production points to a loss-of-function phenotype. Neth. J. Med. 63, 305-308.
126. van Heel, D. A., Ghosh, S., Butler, M., Hunt, K. A., Lundberg, A. M., Ahmad, T., McGovern, D. P., Onnie, C., Negoro, K., Goldthorpe, S., Foxwell, B. M., Mathew, C. G., Forbes, A., Jewell, D. P., Playford, R. J. (2005) Muramyl dipeptide and Toll-like receptor sensitivity in NOD2-associated Crohn's disease. Lancet 365, 1794-1796.
127. Kramer, M., Netea, M. G., de Jong, D. J., Kullberg, B. J., Adema, G. J. (2006) Impaired dendritic cell function in Crohn's disease patients with NOD2 3020insC mutation. J. Leukoc. Biol. 79, 860-866.
128. Blau, E. B. (1985) Familial granulomatous arthritis, iritis, and rash. J. Pediatr. 107, 689-693.
129. Tromp, G., Kuivaniemi, H., Raphael, S., Ala-Kokko, L., Christiano, A., Considine, E., Dhulipala, R., Hyland, J., Jokinen, A., Kivirikko, S., Korn, R., Madhatheri, S., McCarron, S., Pulkkinen, L., Punnett, H., Shimoya, K., Spotila, L., Tate, A., Williams, C. J. (1996) Genetic linkage of familial granulomatous inflammatory arthritis, skin rash, and uveitis to chromosome 16. Am. J. Hum. Genet. 59, 1097-1107.
130. Miceli-Richard, C., Lesage, S., Rybojad, M., Prieur, A. M., Manouvrier-Hanu, S., Hafner, R., Chamaillard, M., Zouali, H., Thomas, G., Hugot, J. P. (2001) CARD15 mutations in Blau syndrome. Nat. Genet. 29, 19-20.
131. Wang, X., Kuivaniemi, H., Bonavita, G., Mutkus, L., Mau, U., Blau, E., Inohara, N., Nunez, G., Tromp, G., Williams, C. J. (2002) CARD15 mutations in familial granulomatosis syndromes: a study of the original Blau syndrome kindred and other families with large-vessel arteritis and cranial neuropathy. Arthritis Rheum. 46, 3041-3045.
132. Van Duist, M. M., Albrecht, M., Podswiadek, M., Giachino, D., Lengauer, T., Punzi, L., De Marchi, M. (2005) A new CARD15 mutation in Blau syndrome. Eur. J. Hum. Genet. 13, 742-747.
133. Rose, C. D., Doyle, T. M., McIlvain-Simpson, G., Coffman, J. E., Rosenbaum, J. T., Davey, M. P., Martin, T. M. (2005) Blau syndrome mutation of CARD15/NOD2 in sporadic early onset granulomatous arthritis. J. Rheumatol. 32, 373-375.
134. Kanazawa, N., Okafuji, I., Kambe, N., Nishikomori, R., Nakata-Hizume, M., Nagai, S., Fuji, A., Yuasa, T., Manki, A., Sakurai, Y., Nakajima, M., Kobayashi, H., Fujiwara, I., Tsutsumi, H., Utani, A., Nishigori, C., Heike, T., Nakahata, T., Miyachi, Y. (2005) Early-onset sarcoidosis and CARD15 mutations with constitutive nuclear factor-κB activation: common genetic etiology with Blau syndrome. Blood 105, 1195-1197.
135. Rosenstiel, P., Till, A., Schreiber, S. (2007) NOD-like receptors and human diseases. Microbes Infect. 9, 648-657.
136. Muckle, T. J. (1979) The 'Muckle-Wells' syndrome. Br. J. Dermatol. 100, 87-92.
137. Neven, B., Callebaut, I., Prieur, A. M., Feldmann, J., Bodemer, C., Lepore, L., Derfalvi, B., Benjaponpitak, S., Vesely, R., Sauvain, M. J., Oertle, S., Allen, R., Morgan, G., Borkhardt, A., Hill, C., Gardner-Medwin, J., Fischer, A., de Saint Basile, G. (2004) Molecular basis of the spectral expression of CIAS1 mutations associated with phagocytic cell-mediated autoinflammatory disorders CINCA/NOMID, MWS, and FCU. Blood 103, 2809-2815.
138. Prieur, A. M., Griscelli, C., Lampert, F., Truckenbrodt, H., Guggenheim, M. A., Lovell, D. J., Pelkonnen, P., Chevrant-Breton, J., Ansell, B. M. (1987) A chronic, infantile, neurological, cutaneous and articular (CINCA) syndrome. A specific entity analyzed in 30 patients. Scand. J. Rheumatol. Suppl. 66, 57-68.
139. Feldmann, J., Prieur, A. M., Quartier, P., Berquin, P., Certain, S., Cortis, E., Teillac-Hamel, D., Fischer, A., de Saint Basile, G. (2002) Chronic infantile neurological cutaneous and articular syndrome is caused by mutations in CIAS1, a gene highly expressed in polymorphonuclear cells and chondrocytes. Am. J. Hum. Genet. 71, 198-203.
140. Dowds, T. A., Masumoto, J., Zhu, L., Inohara, N., Nunez, G. (2004) Cryopyrin-induced interleukin 1β secretion in monocytic cells: enhanced activity of disease-associated mutants and requirement for ASC. J. Biol. Chem. 279, 21924-21928.
141. Alkhateeb, A., Fain, P. R., Thody, A., Bennett, D. C., Spritz, R. A. (2003) Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Res. 16, 208-214.
142. Laberge, G., Mailloux, C. M., Gowan, K., Holland, P., Bennett, D. C., Fain, P. R., Spritz, R. A. (2005) Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 18, 300-305.
143. Jin, Y., Mailloux, C. M., Gowan, K., Riccardi, S. L., LaBerge, G., Bennett, D. C., Fain, P. R., Spritz, R. A. (2007) NALP1 in vitiligoa-ssociated multiple autoimmune disease. N. Engl. J. Med. 356, 1216-1225.
144. Jin, Y., Birlea, S.A., Fain, P.R., Spritz, R.A. (2007) Genetic variations in NALP1 are associated with generalized vitiligo in a Romanian population. J. Invest. Dermatol., Epub ahead of print.
145. Harton, J. A., O'Connor Jr., W., Conti, B. J., Linhoff, M. W., Ting, J. P. (2002) Leucine-rich repeats of the class II transactivator control its rate of nuclear accumulation. Hum. Immunol. 63, 588-601.
146. Steimle, V., Otten, L. A., Zufferey, M., Mach, B. (1993) Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome). Cell 75, 135-146.
147. Reith, W., Mach, B. (2001) The bare lymphocyte syndrome and the regulation of MHC expression. Annu. Rev. Immunol. 19, 331-373.
148. Nickerson, K., Sisk, T. J., Inohara, N., Yee, C. S. K., Kennell, J., Cho, M-C., Yannie II, P. J., Nunez, G., Chang, C.-H. (2001) Dendritic cell-specific MHC class II transactivator contains a caspase recruitment domain that confers potent transactivation activity. J. Biol. Chem. 276, 19089-19093.
149. DeSandro, A., Nagarajan, U. M., Boss, J. M. (1999) The bare lymphocyte syndrome: molecular clues to the transcriptional regulation of major histocompatibility complex class II genes. Am. J. Hum. Genet. 65, 279-286.
150. Zika, E., Fauquier, L., Vandel, L., Ting, J. P. (2005) Interplay among coactivator-associated arginine methyltransferase 1, CBP, and CIITA in IFN-γ-inducible MHC-II gene expression. Proc. Natl. Acad. Sci. USA 102, 16321-16326.
151. Zika, E., Ting, J. P. (2005) Epigenetic control of MHC-II: interplay between CIITA and histone-modifying enzymes. Curr. Opin. Immunol. 17, 58-64.
152. Onen, F. (2006) Familial Mediterranean fever. Rheumatol. Int. 26, 489-496.
153. Ting, J. P., Kastner, D. L., Hoffman, H. M. (2006) CATERPILLERs, pyrin and hereditary immunological disorders. Nat. Rev. Immunol. 6, 183-195.
154. Jeru, I., Papin, S., L'Hoste, S., Duquesnoy, P., Cazeneuve, C., Camonis, J., Amselem, S. (2005) Interaction of pyrin with 14.3.3 in an isoform-specific and phosphorylation-dependent manner regulates its translocation to the nucleus. Arthritis Rheum. 52, 1848-1857.
155. Gershoni-Baruch, R., Brik, R., Shinawi, M., Livneh, A. (2002) The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur. J. Hum. Genet. 10, 145-149.
156. Podolsky, D. K. (2002) Inflammatory bowel disease. N. Engl. J. Med. 347, 417-429.
157. Adam, A., Petit, J. F., Lefrancier, P., Lederer, E. (1981) Muramyl peptides. Chemical structure, biological activity and mechanism of action. Mol. Cell. Biochem. 41, 27-47.
158. Bahr, G. M., Chedid, L. (1986) Immunological activities of muramyl peptides. Fed. Proc. 45, 2541-2544.
159. Hadden, J. W. (1993) Immunostimulants. Trends Pharmacol. Sci. 14, 169-174.
160. Azuma, I., Seya, T. (2001) Development of immunoadjuvants for immunotherapy of cancer. Int. Immunopharmacol. 1, 1249-1259.
161. Nardin, A., Lefebvre, M. L., Labroquere, K., Faure, O., Abastado, J. P. (2006) Liposomal muramyl tripeptide phosphatidylethanolamine: targeting and activating macrophages for adjuvant treatment of osteosarcoma. Curr. Cancer Drug Targets 6, 123-133.
162. Muramatsu, K., You-Xin, S., Hashimoto, T., Matsunaga, T., Taguchi, T. (2006) The role of cyclophosphamide and granulocyte colony-stimulation factor in achieving high-level chimerism in allotransplanted limbs. J. Orthop. Res. 24, 2133-2140.
163. Meyers, P. A., Schwartz, C. L., Krailo, M., Kleinerman, E. S., Betcher, D., Bernstein, M. L., Conrad, E., Ferguson, W., Gebhardt, M., Goorin, A. M., Harris, M. B., Healey, J., Huvos, A., Link, M., Montebello, J., Nadel, H., Nieder, M., Sato, J., Siegal, G., Weiner, M., Wells, R., Wold, L., Womer, R., Grier, H. (2005) Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J. Clin. Oncol. 23, 2004-2011.
164. Petrova, E. E., Valyakina, T. I., Simonova, M. A., Komaleva, R. L., Khaidukov, S. V., Makarov, E. A., Blokhin, D. Y., Ivanov, P. K., Andronova, T. M., Nesmeyanov, V. A. (2006) Muramyl peptides augment cytotoxic effect of tumor necrosis factor-α in combination with cytotoxic drugs on tumor cells. Int. Immunopharmacol. 6, 1377-1386.
165. Opanasopit, P., Sakai, M., Nishikawa, M., Kawakami, S., Yamashita, F., Hashida, M. (2002) Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers. J. Control. Release 80, 283-294.
166. Meterissian, S., Steele Jr., G. D., Thomas, P. (1993) Human and murine Kupffer cell function may be altered by both intrahepatic and intrasplenic tumor deposits. Clin. Exp. Metastasis 11, 175-182.
167. Honko, A. N., Sriranganathan, N., Lees, C. J., Mizel, S. B. (2006) Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis. Infect. Immun. 74, 1113-1120.
168. Cuadros, C., Lopez-Hernandez, F. J., Dominguez, A. L., McClelland, M., Lustgarten, J. (2004) Flagellin fusion proteins as adjuvants or vaccines induce specific immune responses. Infect. Immun. 72, 2810-2816.
169. McSorley, S. J., Ehst, B. D., Yu, Y., Gewirtz, A. T. (2002) Bacterial flagellin is an effective adjuvant for CD4+ T cells in vivo. J. Immunol. 169, 3914-3919.
170. Ausubel, F. M. (2005) Are innate immune signaling pathways in plants and animals conserved? Nat. Immunol. 6, 973-979.
171. Adam, A., Amar, C., Ciorbaru, R., Lederer, E., Petit, J. F., Vilkas, E. (1974) Adjuvant activity of peptidoglyoans from mycobacteria. C. R. Acad. Sci. Hebd. Seances. Acad. Sci. D 278, 799-801.
172. Ellouz, F., Adam, A., Ciorbaru, R., Lederer, E. (1974) Minimal structural requirements for adjuvant activity of bacterial peptidoglycan derivatives. Biochem. Biophys. Res. Commun. 59, 1317-1325.
173. Fritz, J. H., Le Bourhis, L., Sellge, G., Magalhaes, J. G., Fsihi, H., Kufer, T. A., Collins, C., Viala, J., Ferrero, R. L., Girardin, S. E., Philpott, D. J. (2007) Nod1-mediated innate immune recognition of peptidoglycan contributes to the onset of adaptive immunity. Immunity 26, 445-459.
174. Wehkamp, J., Salzman, N. H., Porter, E., Nuding, S., Weichenthal, M., Petras, R. E., Shen, B., Schaeffeler, E., Schwab, M., Linzmeier, R., Feathers, R. W., Chu, H., Lima Jr., H., Fellermann, K., Ganz, T., Stange, E. F., Bevins, C. L. (2005) Reduced Paneth cell α-defensins in ileal Crohn's disease. Proc. Natl. Acad. Sci. USA 102, 18129-18134.
175. Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R., Memet, S., Huerre, M. R., Coyle, A. J., DiStefano, P. S., Sansonetti, P. J., Labigne, A., Bertin, J., Philpott, D. J., Ferrero, R. L. (2004) Nod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island. Nat. Immunol. 5, 1166-1174.
176. Inohara, N., Ogura, Y., Nunez, G. (2002) Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr. Opin. Microbiol. 5, 76-80.
177. Gutierrez, O., Pipaon, C., Inohara, N., Fontalba, A., Ogura, Y., Prosper, F., Nunez, G., Fernandez-Luna, J. L. (2002) Induction of Nod2 in myelomonocytic and intestinal epithelial cells via nuclear factor-κ B activation. J. Biol. Chem. 277, 41701-41705.
178. Lala, S., Ogura, Y., Osborne, C., Hor, S. Y., Bromfield, A., Davies, S., Ogunbiyi, O., Nunez, G., Keshav, S. (2003) Crohn's disease and the NOD2 gene: a role for Paneth cells. Gastroenterology 125, 47-57.
179. Poyet, J. L., Srinivasula, S. M., Tnani, M., Razmara, M., Fernandes-Alnemri, T., Alnemri, E. S. (2001) Identification of Ipaf, a human caspase-1-activating protein related to Apaf-1. J. Biol. Chem. 276, 28309-28313.
180. Damiano, J. S., Stehlik, C., Pio, F., Godzik, A., Reed, J. C. (2001) CLAN, a novel human CED-4-like gene. Genomics 75, 77-83.
181. Hlaing, T., Guo, R. F., Dilley, K. A., Loussia, J. M., Morrish, T. A., Shi, M. M., Vincenz, C., Ward, P. A. (2001) Molecular cloning and characterization of DEFCAP-L and -S, two isoforms of a novel member of the mammalian Ced-4 family of apoptosis proteins. J. Biol. Chem. 276, 9230-9238.
182. Chu, Z. L., Pio, F., Xie, Z., Welsh, K., Krajewska, M., Krajewski, S., Godzik, A., Reed, J. C. (2001) A novel enhancer of the Apaf1 apoptosome involved in cytochrome c-dependent caspase activation and apoptosis. J. Biol. Chem. 276, 9239-9245.
183. Grenier, J. M., Wang, L., Manji, G. A., Huang, W. J., Al-Garawi, A., Kelly, R., Carlson, A., Merriam, S., Lora, J. M., Briskin, M., DiStefano, P. S., Bertin, J. (2002) Functional screening of five PYPAF family members identifies PYPAF5 as a novel regulator of NF-κB and caspase-1. FEBS Lett. 530, 73-78.
184. Bruey, J. M., Bruey-Sedano, N., Newman, R., Chandler, S., Stehlik, C., Reed, J. C. (2004) PAN1/NALP2/PYPAF2, an inducible inflammatory mediator that regulates NF-κB and caspase-1 activation in macrophages. J. Biol. Chem. 279, 51897-51907.
185. Hamatani, T., Falco, G., Carter, M. G., Akutsu, H., Stagg, C. A., Sharov, A. A., Dudekula, D. B., VanBuren, V., Ko, M. S. (2004) Age-associated alteration of gene expression patterns in mouse oocytes. Hum. Mol. Genet. 13, 2263-2278.
186. Manji, G. A., Wang, L., Geddes, B. J., Brown, M., Merriam, S., Al-Garawi, A., Mak, S., Lora, J. M., Briskin, M., Jurman, M., Cao, J., DiStefano, P. S., Bertin, J. (2002) PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with ASC and regulates activation of NF-κ B. J. Biol. Chem. 277, 11570-11575.
187. Fiorentino, L., Stehlik, C., Oliveira, V., Ariza, M. E., Godzik, A., Reed, J. C. (2002) A novel PAAD-containing protein that modulates NF-κ B induction by cytokines tumor necrosis factor-α and interleukin-1β. J. Biol. Chem. 277, 35333-35340.
188. Tong, Z. B., Bondy, C. A., Zhou, J., Nelson, L. M. (2002) A human homologue of mouse Mater, a maternal effect gene essential for early embryonic development. Hum. Reprod. 17, 903-911.
189. Kinoshita, T., Wang, Y., Hasegawa, M., Imamura, R., Suda, T. (2005) PYPAF3, a PYRIN-containing APAF-1-like protein, is a feedback regulator of caspase-1-dependent interleukin-1β secretion. J. Biol. Chem. 280, 21720-21725.
190. Martinon, F., Tschopp, J. (2005) NLRs join TLRs as innate sensors of pathogens. Trends Immunol. 26, 447-454.
191. Shami, P. J., Kanai, N., Wang, L. Y., Vreeke, T. M., Parker, C. H. (2001) Identification and characterization of a novel gene that is upregulated in leukemia cells by nitric oxide. Br. J. Haematol. 112, 138-147.
192. Roy, N., Mahadevan, M. S., McLean, M., Shutler, G., Yaraghi, Z., Farahani, R., Baird, S., Besner-Johnston, A., Lefebvre, C., Kang, X., et al. (1995) The gene for neuronal apoptosis inhibitory protein is partially deleted in individuals with spinal muscular atrophy. Cell 80, 167-178.
193. Conti, B. J., Davis, B. K., Zhang, J., O'Connor Jr., W., Williams, K. L., Ting, J. P. (2005) CATERPILLER 16.2 (CLR16.2), a novel NBD/LRR family member that negatively regulates T cell function. J. Biol. Chem. 280, 18375-18385.
194. Stehlik, C., Hayashi, H., Pio, F., Godzik, A., Reed, J. C. (2003) CARD6 is a modulator of NF-κ B activation by Nod1- and Cardiak-mediated pathways. J. Biol. Chem. 278, 31941-31949.
195. Centola, M., Wood, G., Frucht, D. M., Galon, J., Aringer, M., Farrell, C., Kingma, D. W., Horwitz, M. E., Mansfield, E., Holland, S. M., O'Shea, J. J., Rosenberg, H. F., Malech, H. L., Kastner, D. L. (2000) The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators. Blood 95, 3223-3231.
196. Tidow, N., Chen, X., Muller, C., Kawano, S., Gombart, A. F., Fischel-Ghodsian, N., Koeffler, H. P. (2000) Hematopoietic-specific expression of MEFV, the gene mutated in familial Mediterranean fever, and subcellular localization of its corresponding protein, pyrin. Blood 95, 1451-1455.
197. Mansfield, E., Chae, J. J., Komarow, H. D., Brotz, T. M., Frucht, D. M., Aksentijevich, I., Kastner, D. L. (2001) The familial Mediterranean fever protein, pyrin, associates with microtubules and colocalizes with actin filaments. Blood 98, 851-859.
198. Chen, X., Bykhovskaya, Y., Tidow, N., Hamon, M., Bercovitz, Z., Spirina, O., Fischel-Ghodsian, N. (2000) The familial Mediterranean fever protein interacts and colocalizes with a putative Golgi transporter. Proc. Soc. Exp. Biol. Med. 224, 32-40.
199. Shiohara, M., Taniguchi, S., Masumoto, J., Yasui, K., Koike, K., Komiyama, A., Sagara, J. (2002) ASC, which is composed of a PYD and a CARD, is up-regulated by inflammation and apoptosis in human neutrophils. Biochem. Biophys. Res. Commun. 293, 1314-1318.
200. Razmara, M., Srinivasula, S. M., Wang, L., Poyet, J. L., Geddes, B. J., DiStefano, P. S., Bertin, J., Alnemri, E. S. (2002) CARD-8 protein, a new CARD family member that regulates caspase-1 activation and apoptosis. J. Biol. Chem. 277, 13952-13958.
201. Bouchier-Hayes, L., Conroy, H., Egan, H., Adrain, C., Creagh, E. M., MacFarlane, M., Martin, S. J. (2001) CARDINAL, a novel caspase recruitment domain protein, is an inhibitor of multiple NF-κ B activation pathways. J. Biol. Chem. 276, 44069-44077.
202. Pathan, N., Marusawa, H., Krajewska, M., Matsuzawa, S., Kim, H., Okada, K., Torii, S., Kitada, S., Krajewski, S., Welsh, K., Pio, F., Godzik, A., Reed, J. C. (2001) TUCAN, an antiapoptotic caspase-associated recruitment domain family protein overexpressed in cancer. J. Biol. Chem. 276, 32220-32229.
203. Uehara, A., Fujimoto, Y., Kawasaki, A., Kusumoto, S., Fukase, K., Takada, H. (2006) Meso-diaminopimelic acid and meso-lanthionine, amino acids specific to bacterial peptidoglycans, activate human epithelial cells through NOD1. J. Immunol. 177, 1796-1804.
204. Hirata, Y., Ohmae, T., Shibata, W., Maeda, S., Ogura, K., Yoshida, H., Kawabe, T., Omata, M. (2006) MyD88 and TNF receptor-associated factor 6 are critical signal transducers in Helicobacter pylori-infected human epithelial cells. J. Immunol. 176, 3796-3803.
205. Girardin, S.E., Travassos, L.H., Herve, M., Blanot, D., Boneca, I.G., Philpott, D.J., Sansonetti, P.J., Mengin-Lecreulx, D. (2003) Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J. Biol. Chem. 278, 41702-41708.
206. Kim, J. G., Lee, S. J., Kagnoff, M. F. (2004) Nod1 is an essential signal transducer in intestinal epithelial cells infected with bacteria that avoid recognition by Toll-like receptors. Infect. Immun. 72, 1487-1495.
207. Magalhaes, J. G., Philpott, D. J., Nahori, M. A., Jehanno, M., Fritz, J., Le Bourhis, L., Viala, J., Hugot, J. P., Giovannini, M., Bertin, J., Lepoivre, M., Mengin-Lecreulx, D., Sansonetti, P. J., Girardin, S. E. (2005) Murine Nod1 but not its human orthologue mediates innate immune detection of tracheal cytotoxin. EMBO Rep. 6, 1201-1207.
208. Uehara, A., Yang, S., Fujimoto, Y., Fukase, K., Kusumoto, S., Shibata, K., Sugawara, S., Takada, H. (2005) Muramyldipeptide and diamin-opimelic acid-containing desmuramylpeptides in combination with chemically synthesized Toll-like receptor agonists synergistically induced production of interleukin-8 in a NOD2- and NOD1-dependent manner, respectively, in human monocytic cells in culture. Cell. Microbiol. 7, 53-61.
209. Greene, C. M., Carroll, T. P., Smith, S. G., Taggart, C. C., Devaney, J., Griffin, S., O'Neill, S. J., McElvaney, N. G. (2005) TLR-induced inflammation in cystic fibrosis and non-cystic fibrosis airway epithelial cells. J. Immunol. 174, 1638-1646.
210. Hasegawa, M., Imamura, R., Kinoshita, T., Matsumoto, N., Masumoto, J., Inohara, N., Suda, T. (2005) ASC-mediated NF-κB activation leading to interleukin-8 production requires caspase-8 and is inhibited by CLARP. J. Biol. Chem. 280, 15122-15130.
211. Opitz, B., Forster, S., Hocke, A. C., Maass, M., Schmeck, B., Hippenstiel, S., Suttorp, N., Krull, M. (2005) Nod1-mediated endothelial cell activation by Chlamydophila pneumoniae. Circ. Res. 96, 319-326.
212. Welter-Stahl, L., Ojcius, D. M., Viala, J., Girardin, S., Liu, W., Delarbre, C., Philpott, D., Kelly, K. A., Darville, T. (2006) Stimulation of the cytosolic receptor for peptidoglycan, Nod1, by infection with Chlamydia trachomatis or Chlamydia muridarum. Cell. Microbiol. 8, 1047-1057.
213. Opitz, B., Puschel, A., Schmeck, B., Hocke, A. C., Rosseau, S., Hammerschmidt, S., Schumann, R. R., Suttorp, N., Hippenstiel, S. (2004) Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae. J. Biol. Chem. 279, 36426-36432.
214. Derre, I., Isberg, R. R. (2004) Macrophages from mice with the restrictive Lgn1 allele exhibit multifactorial resistance to Legionella pneumophila. Infect. Immun. 72, 6221-6229.
215. Gurcel, L., Abrami, L., Girardin, S., Tschopp, J., van der Goot, F. G. (2006) Caspase-1 activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 126, 1135-1145.
216. Ogura, Y., Bonen, D. K., Inohara, N., Nicolae, D. L., Chen, F. F., Ramos, R., Britton, H., Moran, T., Karaliuskas, R., Duerr, R. H., Achkar, J. P., Brant, S. R., Bayless, T. M., Kirschner, B. S., Hanauer, S. B., Nunez, G., Cho, J. H. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606.
217. Hampe, J., Cuthbert, A., Croucher, P. J., Mirza, M. M., Mascheretti, S., Fisher, S., Frenzel, H., King, K., Hasselmeyer, A., MacPherson, A. J., Bridger, S., van Deventer, S., Forbes, A., Nikolaus, S., Lennard-Jones, J. E., Foelsch, U. R., Krawczak, M., Lewis, C., Schreiber, S., Mathew, C. G. (2001) Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations. Lancet 357, 1925-1928.
218. Kanazawa, N., Matsushima, S., Kambe, N., Tachibana, T., Nagai, S., Miyachi, Y. (2004) Presence of a sporadic case of systemic granulomatosis syndrome with a CARD15 mutation. J. Invest. Dermatol. 122, 851-852.
219. Hoffman, H. M., Gregory, S. G., Mueller, J. L., Tresierras, M., Broide, D. H., Wanderer, A. A., Kolodner, R. D. (2003) Fine structure mapping of CIAS1: identification of an ancestral haplotype and a common FCAS mutation, L353P. Hum. Genet. 112, 209-216.
220. Dode, C., Le Du, N., Cuisset, L., Letourneur, F., Berthelot, J. M., Vaudour, G., Meyrier, A., Watts, R. A., Scott, D. G., Nicholls, A., Granel, B., Frances, C., Garcier, F., Edery, P., Boulinguez, S., Domergues, J. P., Delpech, M., Grateau, G. (2002) New mutations of CIAS1 that are responsible for Muckle-Wells syndrome and familial cold urticaria: a novel mutation underlies both syndromes. Am. J. Hum. Genet. 70, 1498-1506.
221. Cressman, D. E., Chin, K. C., Taxman, D. J., Ting, J. P. (1999) A defect in the nuclear translocation of CIITA causes a form of type II bare lymphocyte syndrome. Immunity 10, 163-171.
222. Bontron, S., Steimle, V., Ucla, C., Eibl, M. M., Mach, B. (1997) Two novel mutations in the MHC class II transactivator CIITA in a second patient from MHC class II deficiency complementation group A. Hum. Genet. 99, 541-546.
223. Quan, V., Towey, M., Sacks, S., Kelly, A. P. (1999) Absence of MHC class II gene expression in a patient with a single amino acid substitution in the class II transactivator protein CIITA. Immunogenetics 49, 957-963.
224. Wiszniewski, W., Fondaneche, M. C., Le Deist, F., Kanariou, M., Selz, F., Brousse, N., Steimle, V., Barbieri, G., Alcaide-Loridan, C., Charron, D., Fischer, A., Lisowska-Grospierre, B. (2001) Mutation in the class II trans-activator leading to a mild immunodeficiency. J. Immunol. 167, 1787-1794.
225. Bernot, A., da Silva, C., Petit, J. L., Cruaud, C., Caloustian, C., Castet, V., Ahmed-Arab, M., Dross, C., Dupont, M., Cattan, D., Smaoui, N., Dodé, C., Pêcheux, C., Nédelec, B., Medaxian, J., Rozenbaum, M., Rosner, I., Delpech, M., Grateau, G., Demaille, J., Weissenbach, J., Touitou, I. (1998) Non-founder mutations in the MEFV gene establish this gene as the cause of familial Mediterranean fever (FMF). Hum. Mol. Genet. 7, 1317-1325.